Dassault Systèmes company Medidata Hosts NEXT New York 2023: A Premier Clinical Research Conference

Dassault Systèmes company Medidata Hosts NEXT New York 2023: A Premier Clinical Research Conference

(IN BRIEF) Medidata, a subsidiary of Dassault Systèmes, is hosting NEXT New York 2023, a major clinical research conference in New York City from November 7-8. This event will bring together over 700 leaders in the life sciences industry to explore innovative advancements throughout the clinical research process, from research to commercialization. It will showcase how Medidata is driving change in the clinical landscape, enabling the development of next-generation therapies. The conference will feature presentations by industry experts highlighting how Medidata’s solutions, including its Platform, Rave, Patient Cloud, and AI offerings, are revolutionizing clinical trials by providing faster and more insightful insights. Attendees can also experience interactive exhibits and immersive experiences, including a dedicated innovation lounge, to gain a deeper understanding of cutting-edge clinical research tools and methodologies. To register for the event and stay updated on the agenda, visit MedidataNext2023.com.

(PRESS RELEASE) VELIZY-VILLACOUBLAY, France, 2-Nov-2023 — /EuropaWire/ — Dassault Systèmes SE (EPA: DSY), a French multinational software corporation which develops software for 3D product design, simulation, manufacturing and other 3D related products, announces that its subsidiary Medidata, specializing in clinical trial solutions for the life sciences industry, is set to host NEXT New York 2023, a prominent clinical research conference happening in New York City from November 7-8. Over 700 leaders in the life sciences field will convene to explore groundbreaking innovations spanning the entire life sciences value chain, from research to commercialization.

The conference will highlight how Medidata is reshaping the clinical landscape, emphasizing the development of next-generation therapies. Industry experts, including biopharmaceutical firms, CROs (Contract Research Organizations), and research sites, will present sessions showcasing how Medidata’s cutting-edge solutions like Medidata’s Platform, Rave, Patient Cloud, and AI offerings are revolutionizing clinical trials by enabling faster, more insightful processes. Furthermore, Medidata will introduce a range of new offerings, from advanced intelligent data automation to AI-generated synthetic data, aimed at ushering in an era of patient-centric, intelligent data management and clinical development decision-making.

Throughout the event, attendees can engage in interactive experiences, including a dedicated innovation lounge where they can participate in simulated decentralized clinical trial experiences, interact with data management systems from a patient’s perspective, register for a clinical trial registry, and witness demonstrations of new products in action.

“NEXT New York is a pivotal opportunity to reimagine the life sciences value chain and move the industry forward in ways far beyond clinical trials,” said Michael Pray, chief operating officer of Medidata. “Together with our customers and industry thought leaders, we are transforming the paradigm for life sciences in our pursuit to bring life-saving treatments to patients sooner.”

For registration and updates on the event’s agenda, visit MedidataNext2023.com.

About Medidata